US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist
  • 15.130
  • +0.010+0.07%
Close May 15 16:00 ET
  • 15.130
  • 0.0000.00%
Post 16:00 ET
219.87MMarket Cap-189125P/E (TTM)

Merrimack Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.63%-1.52M
-59.46%-295K
23.11%-203K
28.86%-668K
-0.56%-356K
-699.08%-1.74M
47.89%-185K
40.67%-264K
-192.15%-939K
18.99%-354K
Net income from continuing operations
23.51%-1.18M
51.22%-240K
36.88%-279K
18.20%-391K
-105.30%-271K
37.11%-1.54M
-3.58%-492K
15.81%-442K
37.02%-478K
81.03%-132K
Operating gains losses
68.76%-139K
--0
--0
--0
68.76%-139K
-209.03%-445K
--0
--0
--0
-790.00%-445K
Other non cash items
---298K
----
----
----
----
----
----
----
----
----
Change In working capital
-136.36%-64K
-89.66%30K
3.73%167K
37.66%-298K
-81.77%37K
-91.13%176K
276.62%290K
33.06%161K
-128.37%-478K
100.99%203K
-Change in prepaid assets
-12.09%80K
-45.27%81K
-45.10%84K
33.60%-247K
0.00%162K
-95.85%91K
-54.04%148K
77.91%153K
-123.29%-372K
-13.37%162K
-Change in payables and accrued expense
-648.15%-148K
-136.88%-52K
1,071.43%82K
57.72%-52K
-6,400.00%-126K
112.98%27K
216.53%141K
107.87%7K
-239.77%-123K
102.33%2K
-Change in other current assets
-93.10%4K
0.00%1K
0.00%1K
-94.12%1K
-97.44%1K
--58K
--1K
--1K
--17K
--39K
Cash from discontinued investing activities
Operating cash flow
12.63%-1.52M
-59.46%-295K
23.11%-203K
28.86%-668K
-0.56%-356K
-699.08%-1.74M
47.89%-185K
40.67%-264K
-192.15%-939K
18.99%-354K
Investing cash flow
Cash flow from continuing investing activities
-2,897.53%-12.45M
68K
-3.85M
-8.81M
-68.76%139K
209.03%445K
0
0
0
790.00%445K
Net intangibles purchase and sale
-68.76%139K
--0
--0
--0
-68.76%139K
209.03%445K
--0
--0
--0
790.00%445K
Net investment purchase and sale
---12.59M
--68K
---3.85M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-2,897.53%-12.45M
--68K
---3.85M
---8.81M
-68.76%139K
209.03%445K
--0
--0
--0
790.00%445K
Financing cash flow
Cash flow from continuing financing activities
-92.03%521K
-97.96%133K
0
209K
179K
2,633.47%6.53M
6.53M
0
0
0
Proceeds from stock option exercised by employees
-92.03%521K
-97.96%133K
--0
--209K
--179K
2,633.47%6.53M
--6.53M
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
-92.03%521K
-97.96%133K
--0
--209K
--179K
2,633.47%6.53M
--6.53M
--0
--0
--0
Net cash flow
Beginning cash position
36.87%19.44M
-53.53%6.08M
-24.14%10.13M
35.73%19.4M
36.87%19.44M
1.18%14.2M
-10.08%13.09M
-10.42%13.36M
2.91%14.29M
1.18%14.2M
Current changes in cash
-356.88%-13.45M
-101.48%-94K
-1,433.33%-4.05M
-887.22%-9.27M
-141.76%-38K
3,073.33%5.24M
1,888.17%6.35M
24.79%-264K
-192.15%-939K
161.49%91K
End cash Position
-69.19%5.99M
-69.19%5.99M
-53.53%6.08M
-24.14%10.13M
35.73%19.4M
36.87%19.44M
36.87%19.44M
-10.08%13.09M
-10.42%13.36M
2.91%14.29M
Free cash flow
12.63%-1.52M
-59.46%-295K
23.11%-203K
28.86%-668K
-0.56%-356K
-699.08%-1.74M
47.89%-185K
40.67%-264K
-192.15%-939K
18.99%-354K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.63%-1.52M-59.46%-295K23.11%-203K28.86%-668K-0.56%-356K-699.08%-1.74M47.89%-185K40.67%-264K-192.15%-939K18.99%-354K
Net income from continuing operations 23.51%-1.18M51.22%-240K36.88%-279K18.20%-391K-105.30%-271K37.11%-1.54M-3.58%-492K15.81%-442K37.02%-478K81.03%-132K
Operating gains losses 68.76%-139K--0--0--068.76%-139K-209.03%-445K--0--0--0-790.00%-445K
Other non cash items ---298K------------------------------------
Change In working capital -136.36%-64K-89.66%30K3.73%167K37.66%-298K-81.77%37K-91.13%176K276.62%290K33.06%161K-128.37%-478K100.99%203K
-Change in prepaid assets -12.09%80K-45.27%81K-45.10%84K33.60%-247K0.00%162K-95.85%91K-54.04%148K77.91%153K-123.29%-372K-13.37%162K
-Change in payables and accrued expense -648.15%-148K-136.88%-52K1,071.43%82K57.72%-52K-6,400.00%-126K112.98%27K216.53%141K107.87%7K-239.77%-123K102.33%2K
-Change in other current assets -93.10%4K0.00%1K0.00%1K-94.12%1K-97.44%1K--58K--1K--1K--17K--39K
Cash from discontinued investing activities
Operating cash flow 12.63%-1.52M-59.46%-295K23.11%-203K28.86%-668K-0.56%-356K-699.08%-1.74M47.89%-185K40.67%-264K-192.15%-939K18.99%-354K
Investing cash flow
Cash flow from continuing investing activities -2,897.53%-12.45M68K-3.85M-8.81M-68.76%139K209.03%445K000790.00%445K
Net intangibles purchase and sale -68.76%139K--0--0--0-68.76%139K209.03%445K--0--0--0790.00%445K
Net investment purchase and sale ---12.59M--68K---3.85M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow -2,897.53%-12.45M--68K---3.85M---8.81M-68.76%139K209.03%445K--0--0--0790.00%445K
Financing cash flow
Cash flow from continuing financing activities -92.03%521K-97.96%133K0209K179K2,633.47%6.53M6.53M000
Proceeds from stock option exercised by employees -92.03%521K-97.96%133K--0--209K--179K2,633.47%6.53M--6.53M--0--0--0
Cash from discontinued financing activities
Financing cash flow -92.03%521K-97.96%133K--0--209K--179K2,633.47%6.53M--6.53M--0--0--0
Net cash flow
Beginning cash position 36.87%19.44M-53.53%6.08M-24.14%10.13M35.73%19.4M36.87%19.44M1.18%14.2M-10.08%13.09M-10.42%13.36M2.91%14.29M1.18%14.2M
Current changes in cash -356.88%-13.45M-101.48%-94K-1,433.33%-4.05M-887.22%-9.27M-141.76%-38K3,073.33%5.24M1,888.17%6.35M24.79%-264K-192.15%-939K161.49%91K
End cash Position -69.19%5.99M-69.19%5.99M-53.53%6.08M-24.14%10.13M35.73%19.4M36.87%19.44M36.87%19.44M-10.08%13.09M-10.42%13.36M2.91%14.29M
Free cash flow 12.63%-1.52M-59.46%-295K23.11%-203K28.86%-668K-0.56%-356K-699.08%-1.74M47.89%-185K40.67%-264K-192.15%-939K18.99%-354K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg